Clinical trialNCT02146066AvailableExpanded Access

Expanded Access Protocol for GBM Patients With Already Manufactured DCVax®-L Who Have Screen-Failed Protocol 020221

SponsorNorthwest BiotherapeuticsGBMGlioblastoma Multiforme

View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

No overall officials are registered on this study record. Site-level investigators, where published, appear with their sites below. Why? →

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

27 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States

University of Arkansas for Medical Sciences
Little Rock, Arkansas, United States
Shirley Ong, MD
Available
Ucla Medical Center
Los Angeles, California, United States
Linda Liau, MD
Available
Hoag Memorial Hospital
Newport Beach, California, United States
Christopher Duma, MD
Available
St. Joseph Hospital of Orange
Orange, California, United States
William Loudon, MD
Available
University of California, Irvine Medical Center
Orange, California, United States
Daniela Bota, MD
Available
University of Colorado Cancer Center
Aurora, Colorado, United States
Kevin Lillehei, MD
Available
Colorado Neurological Institute
Englewood, Colorado, United States
Michael Pearlman, MD
Available
University of Florida
Gainesville, Florida, United States
David Tran, MD
Available
Memorial Healthcare System Memorial Cancer Institute
Hollywood, Florida, United States
Atif Hussein, MD
Available
Cadence Cancer Center at Warrenville
Warrenville, Illinois, United States
Sean Grimm, MD
Available
Beth Israel Deaconess Medical Center
Boston, Massachusetts, United States
David Avigan, MD
Available
Spectrum Health
Grand Rapids, Michigan, United States
Wendy Sherman, MD
Available
John Nasseff Neuroscience Institute - Abott Northwestern Hospital
Minneapolis, Minnesota, United States
John Trusheim, MD
Available
Saint Luke'S Hospital of Kansas City
Kansas City, Missouri, United States
Darren Lovick, MD
Available
Washington University School of Medicine
St Louis, Missouri, United States
Jian Campian, MD
Available
John Theurer Cancer Center at Hackensack University Medical Center
Hackensack, New Jersey, United States
Samuel Goldlust, MD
Available
Capital Health
Trenton, New Jersey, United States
Arlan Mintz, MD
Available
North Shore University Hospital
Manhasset, New York, United States
Available
Columbia University Medical Center Neurological Institute of New York
New York, New York, United States
Fabio Iwamoto, MD
Available
Stony Brook University Hospital
Stony Brook, New York, United States
Raphael Davis, M.D.
Available
Ohio State University
Columbus, Ohio, United States
J. Bradley Elder, MD
Available
University of Oklahoma Health Science Center
Oklahoma City, Oklahoma, United States
James Battiste, MD
Available
Geisinger Medical Center
Danville, Pennsylvania, United States
Steven Toms, MD
Available
Hospital of the University of Pennsylvania
Philadelphia, Pennsylvania, United States
Steven Brem, MD
Available
Saint Thomas Research Institute
Nashville, Tennessee, United States
Steve Abram, MD
Available
Swedish Neuroscience Institute
Seattle, Washington, United States
Charles Cobbs, M.D.
Available
Aurora Saint Luke'S Medical Center
Milwaukee, Wisconsin, United States
George Bobustuc, MD
Available

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: —
Primary completion: —
Completion: —
Last update posted: 26 Feb 2016
Registered enrollment: —
Registry id: NCT02146066

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.